Vaccine Adjuvants Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Brenntag Biosector (Denmark), CSL Limited (Australia)

Acknowledging the kind of traction gained by this market, Industry data Analytics recently published a study report asserts the global Vaccine Adjuvants Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 12.6% during the review period (2022 to 2027).

Vaccine Adjuvants Market Overview

The market is experiencing growth due to rising awareness regarding various medical applications such as pain management, appetite enhancement, and reducing eye pressure.Vaccine Adjuvants is mainly classified into two types, namely Cannabis Sativa and Cannabis indica, which originate from the countries of the Western hemisphere and Central and South Asian regions respectively. The growing number of countries legalizing the use of Vaccine Adjuvants in various parts of this world is one of the key factors driving the usage rate of cannabis in therapeutic applications.

Based on application, the pain management segment is expected to dominate this market, owing to increasing incidence of pain related conditions, such as migraine, cancer pain and others. For instance, in previous year, the Centers for Disease Control and Prevention (CDC) reported that an estimated 50 million Americans, or just over 20%, have some form of chronic pain. People suffering from chronic pain tend to adopt high dosage of painkiller for instant relief. Though, growing intake of painkillers may result in multiple side effects. Hence, the medical community initiated the usage of cannabis as an alternative for pain management, thereby augmenting the market growth.

Industry Developments:

August 2 2021: Agenus (NASDAQ: AGEN), an immuno-oncology company with a wide range of antibodies, cell treatments, supplements, and vaccines designed to convert antibodies to cancer and infection.

August 7, 2021: Shares of biotech company Novavax NVAX plummeted to 19.6% on Friday trading after delays in US delivery of its third Covid-19 vaccine. Novavax said it now expects to apply for an authorization for emergency use in the U.S. In the fourth quarter of this year.

 

Who are the Major Players in Vaccine Adjuvants Market?

The Vaccine Adjuvants Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this market includes Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France) and others.

What are the major Applications, Types and Regions for Vaccine Adjuvants Market?

Vaccine Adjuvants Market is segmented based on the type, applications, companies and regions.

By Product Type, it is segmented into

• Pathogen


• Adjuvant Emulsion


• Particulate


• Combination

By Route of Administration

• Oral


• Intradermal


• Intranasal


• Intramuscular


• Others

By Application it is segmented into

• Infectious Diseases


• Cancer


• Others

Route of Application Category

• Human Vaccine Adjuvants


• Veterinary Vaccine Adjuvants

Vaccine Adjuvants Market Regional Analysis

North America dominates the vaccine adjuvants market owing to the well-established veterinary healthcare infrastructure. Asia-Pacific is anticipated to score maximum growth rate and exhibit the highest CAGR for the forecast period 2022-2027. This is because of the rising expenditure to develop veterinary healthcare infrastructure and increased focus of the government towards immunization programs. In addition, according to the National Clinical Trials (NCT) Registry, as of September 21, 2020, in the United States, nearly 500 vaccine clinical trials are under development, which are anticipated to have an optimistic impact on the study market for these services. They are effective in increasing or activating the immune system. Therefore, ongoing clinical trials related to vaccine development and high-quality research activities in the United States are anticipated to further the market growth studied in North America in the forecast period.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

What is our Vaccine Adjuvants Market report scope?

 

Report Attributes	Report Details
Forecast Period 2022 to 2027 CAGR	CAGR of 12.6% during the review period (2022 to 2027).
By Type	By Product Type, it is segmented into Pathogen Adjuvant Emulsion Particulate Combination By Route of Administration Oral Intradermal Intranasal Intramuscular Others
By Application	By Application it is segmented into Infectious Diseases Cancer Others Route of Application Category Human Vaccine Adjuvants Veterinary Vaccine Adjuvants
By Companies	Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).
Regions Covered	North America Europe Asia-Pacific Rest of the World
Countries Covered	US Canada Germany France UK Italy Spain Rest of Europe China Japan India Australia South Korea Rest of Asia-Pacific Middle East & Africa Latin America
Base Year	2022
Historical Year	2017 to 2021
Forecast Year	2022 to 2027
Number of Pages	113
Customization Available	Yes, the report can be customized as per your needs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Key Takeaways from this Vaccine Adjuvants Report

• Evaluate Vaccine Adjuvants market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Market share held by each application segment with respect to the market renumeration and sales estimates over the forecast timeline are stated in the report.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Vaccine Adjuvants market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.


• It further investigates the specifics that are positively impacting the profit graph of this business sphere.


• The study also elaborates the critical factors which will augment the commercial terrain of the Vaccine Adjuvants market.

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.

Frequently Asked Questions

What is the study period of this market?

The Vaccine Adjuvants Market is studied from 2017 - 2027.

What is the growth rate of Vaccine Adjuvants Market?

The Vaccine Adjuvants Market is growing at a CAGR of 12.6% over the next 5 years.

Who are the leading key players in Vaccine Adjuvants Market?

Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

What regions regions does this Vaccine Adjuvants Market report covers?

North America (the United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, and Italy)

Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

South America (Brazil, Argentina, Colombia, etc.)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

What are the significant types of Vaccine Adjuvants Market?

Pathogen, Adjuvant Emulsion, Particulate, Combination, Others

What are the significant Applications of Vaccine Adjuvants Market?

Infectious Diseases, Cancer, Others